1. Home
  2. CDXS vs BPRN Comparison

CDXS vs BPRN Comparison

Compare CDXS & BPRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • BPRN
  • Stock Information
  • Founded
  • CDXS 2002
  • BPRN 2007
  • Country
  • CDXS United States
  • BPRN United States
  • Employees
  • CDXS N/A
  • BPRN N/A
  • Industry
  • CDXS Major Chemicals
  • BPRN Major Banks
  • Sector
  • CDXS Industrials
  • BPRN Finance
  • Exchange
  • CDXS Nasdaq
  • BPRN Nasdaq
  • Market Cap
  • CDXS 230.3M
  • BPRN 191.5M
  • IPO Year
  • CDXS 2010
  • BPRN N/A
  • Fundamental
  • Price
  • CDXS $2.11
  • BPRN $28.45
  • Analyst Decision
  • CDXS Buy
  • BPRN Strong Buy
  • Analyst Count
  • CDXS 2
  • BPRN 1
  • Target Price
  • CDXS $11.00
  • BPRN $35.00
  • AVG Volume (30 Days)
  • CDXS 1.1M
  • BPRN 11.1K
  • Earning Date
  • CDXS 05-01-2025
  • BPRN 04-28-2025
  • Dividend Yield
  • CDXS N/A
  • BPRN 4.19%
  • EPS Growth
  • CDXS N/A
  • BPRN N/A
  • EPS
  • CDXS N/A
  • BPRN 1.55
  • Revenue
  • CDXS $59,345,000.00
  • BPRN $69,578,000.00
  • Revenue This Year
  • CDXS $12.62
  • BPRN $13.44
  • Revenue Next Year
  • CDXS $22.11
  • BPRN $16.24
  • P/E Ratio
  • CDXS N/A
  • BPRN $18.35
  • Revenue Growth
  • CDXS N/A
  • BPRN 0.35
  • 52 Week Low
  • CDXS $1.90
  • BPRN $27.25
  • 52 Week High
  • CDXS $6.08
  • BPRN $39.35
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 35.96
  • BPRN 39.49
  • Support Level
  • CDXS $1.91
  • BPRN $27.61
  • Resistance Level
  • CDXS $2.47
  • BPRN $30.68
  • Average True Range (ATR)
  • CDXS 0.21
  • BPRN 1.12
  • MACD
  • CDXS 0.02
  • BPRN -0.04
  • Stochastic Oscillator
  • CDXS 23.86
  • BPRN 32.00

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About BPRN Princeton Bancorp Inc. (PA)

Princeton Bancorp Inc is a banking company. It is a full-service financial institution that provides business and personal banking. Its personal banking and business banking services include checking accounts and savings accounts. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The Bank also has two retail branches and conducts loan origination activities in select areas of the New York City metropolitan area.

Share on Social Networks: